National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins

    NEXT STORY
    BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia
    PREV STORY
    Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March

    REDWOOD CITY, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

    author_avatar
    NASDAQ Market News

    Proactive MD amplifies patient care offerings with Wellness for Life acquisition

    author_avatar
    NASDAQ Market News

    ADMA Biologics Reports Third Quarter 2018 Financial Results

    RAMSEY, N.J. and BOCA RATON, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, ...

    author_avatar
    NASDAQ Market News